Clinicopathologic and Immunohistochemical Characteristics of Solitary Fibrous Tumor and Its Mimics: A Single-Center Experience.
Immunohistochemistry
STAT6
Solitary fibrous tumor
Journal
Clinical pathology (Thousand Oaks, Ventura County, Calif.)
ISSN: 2632-010X
Titre abrégé: Clin Pathol
Pays: United States
ID NLM: 101741182
Informations de publication
Date de publication:
Historique:
received:
29
03
2021
accepted:
02
06
2021
entrez:
19
7
2021
pubmed:
20
7
2021
medline:
20
7
2021
Statut:
epublish
Résumé
Solitary fibrous tumor (SFT) is a fibroblastic tumor that has been originally reported as a pleural tumor but now has been defined as a tumor that can be seen everywhere in the human body. Histopathologically, many of the fibroblastic tumors can mimic SFT, and immunohistochemistry is necessary for differential diagnosis. Several markers have been used, and recently, STAT6 has been introduced as a diagnostic marker. No research study has been reported from Iran. In this report, we are trying to introduce our experience about the clinicopathologic findings of 35 cases of SFT during the last 10 years from our center with an emphasis on the diagnostic role of STAT6 in this tumor. During the last 10 years, we confirmed the diagnosis of 35 cases of SFT in the pathology archives of Shiraz University of Medical Sciences. These 35 cases were considered as cases. All the clinicopathologic findings were also extracted from the clinical charts of the patients. To evaluate the diagnostic role of STAT6, another 35 cases of spindle cell tumors were also extracted from the pathology archives as mimickers of SFT. STAT6 was stained in all of the 70 cases and controls. Our experience showed that SFT is more common in middle-aged men with a wide age range, although it is very rare in children. It can be present in every location with a wide size range from less than 1 cm to more than 15 cm. The presence of abnormal staghorn vessels is one of the main diagnostic histopathologic characteristics. STAT6 showed a sensitivity and specificity of 91% and 86% in the diagnosis of SFT. Other markers such as CD99, CD34, and BCL2 have also been considered useful in the differential diagnosis of this tumor, although the diagnostic accuracy seems to be lower than STAT6. High mitosis, presence of necrosis, and atypia are important criteria for predicting malignant and aggressive behavior in SFT. Among 35 cases in our study, 17% showed malignant behavior as recurrent or metastatic tumors. Solitary fibrous tumor is a common soft tissue tumor that can be seen everywhere and needs careful histopathologic and immunohistochemical evaluation for the correct diagnosis and prediction of aggressive or benign behavior.
Sections du résumé
BACKGROUND
BACKGROUND
Solitary fibrous tumor (SFT) is a fibroblastic tumor that has been originally reported as a pleural tumor but now has been defined as a tumor that can be seen everywhere in the human body. Histopathologically, many of the fibroblastic tumors can mimic SFT, and immunohistochemistry is necessary for differential diagnosis. Several markers have been used, and recently, STAT6 has been introduced as a diagnostic marker. No research study has been reported from Iran.
OBJECTIVES
OBJECTIVE
In this report, we are trying to introduce our experience about the clinicopathologic findings of 35 cases of SFT during the last 10 years from our center with an emphasis on the diagnostic role of STAT6 in this tumor.
PATIENTS AND METHODS
METHODS
During the last 10 years, we confirmed the diagnosis of 35 cases of SFT in the pathology archives of Shiraz University of Medical Sciences. These 35 cases were considered as cases. All the clinicopathologic findings were also extracted from the clinical charts of the patients. To evaluate the diagnostic role of STAT6, another 35 cases of spindle cell tumors were also extracted from the pathology archives as mimickers of SFT. STAT6 was stained in all of the 70 cases and controls.
RESULTS AND DISCUSSION
CONCLUSIONS
Our experience showed that SFT is more common in middle-aged men with a wide age range, although it is very rare in children. It can be present in every location with a wide size range from less than 1 cm to more than 15 cm. The presence of abnormal staghorn vessels is one of the main diagnostic histopathologic characteristics. STAT6 showed a sensitivity and specificity of 91% and 86% in the diagnosis of SFT. Other markers such as CD99, CD34, and BCL2 have also been considered useful in the differential diagnosis of this tumor, although the diagnostic accuracy seems to be lower than STAT6. High mitosis, presence of necrosis, and atypia are important criteria for predicting malignant and aggressive behavior in SFT. Among 35 cases in our study, 17% showed malignant behavior as recurrent or metastatic tumors.
CONCLUSION
CONCLUSIONS
Solitary fibrous tumor is a common soft tissue tumor that can be seen everywhere and needs careful histopathologic and immunohistochemical evaluation for the correct diagnosis and prediction of aggressive or benign behavior.
Identifiants
pubmed: 34278302
doi: 10.1177/2632010X211028209
pii: 10.1177_2632010X211028209
pmc: PMC8255563
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2632010X211028209Informations de copyright
© The Author(s) 2021.
Déclaration de conflit d'intérêts
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Références
Mod Pathol. 1997 May;10(5):443-50
pubmed: 9160308
Onco Targets Ther. 2020 Jul 12;13:6819-6826
pubmed: 32764969
Am J Surg Pathol. 2014 Apr;38(4):552-9
pubmed: 24625420
Acta Neuropathol. 2013 May;125(5):651-8
pubmed: 23575898
Nat Genet. 2013 Feb;45(2):180-5
pubmed: 23313952
Mod Pathol. 2015 Oct;28(10):1324-35
pubmed: 26226844
Ann Surg. 1942 Jul;116(1):26-33
pubmed: 17858068
J Thorac Oncol. 2012 Nov;7(11):1698-706
pubmed: 23070244
Ann Diagn Pathol. 2018 Jun;34:142-150
pubmed: 29660566
Mod Pathol. 2012 Sep;25(9):1298-306
pubmed: 22575866
Appl Immunohistochem Mol Morphol. 2020 Apr;28(4):311-315
pubmed: 30664532
Hum Pathol. 2016 Aug;54:184-8
pubmed: 27068523
Cancer. 2002 Feb 15;94(4):1057-68
pubmed: 11920476
Int J Surg Pathol. 2016 Jun;24(4):281-92
pubmed: 26811389
Am J Surg Pathol. 1998 Dec;22(12):1501-11
pubmed: 9850176
Iran J Pathol. 2016 Summer;11(3):195-203
pubmed: 27799967
Nat Genet. 2013 Feb;45(2):131-2
pubmed: 23313954
AJR Am J Roentgenol. 2010 Jul;195(1):W55-62
pubmed: 20566782
Am J Surg Pathol. 2008 Nov;32(11):1627-42
pubmed: 18753943
Mod Pathol. 2014 Mar;27(3):390-5
pubmed: 24030747
Diagn Pathol. 2014 Nov 29;9:224
pubmed: 25432794
Int J Oncol. 2015;46(6):2595-605
pubmed: 25901508
Am J Surg Pathol. 1989 Aug;13(8):640-58
pubmed: 2665534
Am J Surg Pathol. 2011 Aug;35(8):1177-85
pubmed: 21716088
J Thorac Oncol. 2015 Feb;10(2):309-15
pubmed: 25319181
Am J Surg Pathol. 2012 Aug;36(8):1119-28
pubmed: 22790852